- Clinical Trials
- April 2024
- 60 Pages
Global
From €1908EUR$2,000USD£1,598GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1908EUR$2,000USD£1,598GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£999GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1431EUR$1,500USD£1,199GBP
- Report
- March 2024
- 257 Pages
Global
From €7156EUR$7,500USD£5,994GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1431EUR$1,500USD£1,199GBP
- Report
- September 2024
- 181 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- August 2024
- 187 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- July 2024
- 183 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- February 2024
- 184 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- November 2023
- 182 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Report
- October 2024
- 146 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Report
- March 2024
- 155 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Report
- March 2024
- 200 Pages
Global
From €3960EUR$4,150USD£3,317GBP
- Report
- January 2024
- 200 Pages
Global
From €3960EUR$4,150USD£3,317GBP
- Clinical Trials
- April 2024
- 1332 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Report
- November 2023
- 47 Pages
Global
From €3812EUR$3,995USD£3,193GBP
- Report
- August 2024
- 83 Pages
Global
From €3500EUR$3,930USD£3,034GBP
- Report
- January 2024
- 73 Pages
Global
From €3500EUR$3,930USD£3,034GBP
The Leukemia Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat leukemia, a type of cancer of the blood and bone marrow. These drugs are used to reduce the number of cancer cells in the body, and to prevent the spread of the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells, and immunotherapy is a type of drug that works by stimulating the body's immune system to fight cancer cells.
The Leukemia Drugs market is highly competitive, with many companies competing for market share. Some of the major players in the market include Novartis, Pfizer, Bristol-Myers Squibb, Celgene, and Amgen. Show Less Read more